Related Experiment Videos
[Early experience with the advanced breast biopsy instrumentation system in a multicentre study]
Gynakologisch-Geburtshilfliche Rundschau
|October 10, 2002
Summary
The Advanced Breast Biopsy Instrumentation (ABBI) system offers a safe and accurate alternative for non-palpable breast lesion biopsies. While effective, further research is needed to determine its therapeutic role in breast cancer treatment.
Area of Science:
- Radiology
- Surgical Oncology
- Medical Device Technology
Background:
- Non-palpable breast lesions require accurate diagnostic methods.
- Minimally invasive biopsy techniques are preferred for patient comfort and reduced complications.
- The Advanced Breast Biopsy Instrumentation (ABBI) system was developed for stereotactic excision biopsies.
Purpose of the Study:
- To evaluate the early experience and feasibility of the ABBI system in a multicentre setting.
- To assess the safety, accuracy, and patient comfort of ABBI compared to traditional open biopsy.
- To identify technical limitations of the ABBI system.
Main Methods:
- A multicentre trial conducted in Austria from September 1998 to December 2001.
- 474 procedures were performed using the ABBI system.
- 389 procedures were included in the study protocol for analysis.
Main Results:
- The ABBI system demonstrated patient comfort, radiological accuracy, and a low complication rate.
- Stereotactic excision biopsy using ABBI is a viable alternative to open biopsy for non-palpable lesions.
- Technical limitations associated with the ABBI system were observed.
Conclusions:
- The ABBI system is a useful alternative for the stereotactic excision biopsy of non-palpable breast lesions.
- Further investigation is required to determine the therapeutic implications of breast cancer treatment using ABBI.
- The study highlights the potential of ABBI while acknowledging existing technical challenges.